Nidal Boulos

1.2k total citations
23 papers, 720 citations indexed

About

Nidal Boulos is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Nidal Boulos has authored 23 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Genetics and 5 papers in Oncology. Recurrent topics in Nidal Boulos's work include Glioma Diagnosis and Treatment (7 papers), Neuroblastoma Research and Treatments (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Nidal Boulos is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Neuroblastoma Research and Treatments (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Nidal Boulos collaborates with scholars based in United States, United Kingdom and Australia. Nidal Boulos's co-authors include Richard J. Gilbertson, Clinton F. Stewart, David Finkelstein, Martine F. Roussel, Yogesh T. Patel, Timothy N. Phoenix, Megan O. Jacus, Sébastien Perreault, Deanna M. Patmore and Elizabeth Wadhwa and has published in prestigious journals such as Nature Genetics, Blood and Neurology.

In The Last Decade

Nidal Boulos

21 papers receiving 716 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nidal Boulos United States	11	424	225	135	123	101	23	720
Deanna M. Patmore United States	7	627 1.5×	157 0.7×	85 0.6×	63 0.5×	100 1.0×	8	863
Arnaud Lombard Belgium	11	305 0.7×	170 0.8×	198 1.5×	170 1.4×	69 0.7×	23	614
Irune Ruiz Spain	13	348 0.8×	151 0.7×	164 1.2×	40 0.3×	207 2.0×	25	672
Hiromasa Tsuiki Japan	13	521 1.2×	128 0.6×	202 1.5×	294 2.4×	157 1.6×	20	903
Uday Bhanu Maachani United States	13	257 0.6×	149 0.7×	108 0.8×	121 1.0×	73 0.7×	20	533
Demirkan Gursel United States	19	491 1.2×	243 1.1×	270 2.0×	64 0.5×	284 2.8×	32	970
Amanda Linkous United States	14	525 1.2×	263 1.2×	247 1.8×	85 0.7×	200 2.0×	22	886
Ningyi Tiao United States	10	436 1.0×	270 1.2×	218 1.6×	43 0.3×	156 1.5×	13	768
Zeng-jie Yang China	16	426 1.0×	193 0.9×	159 1.2×	70 0.6×	132 1.3×	51	757
Uwe Schlomann Germany	17	466 1.1×	68 0.3×	307 2.3×	115 0.9×	211 2.1×	28	945

Countries citing papers authored by Nidal Boulos

Since Specialization

Citations

This map shows the geographic impact of Nidal Boulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nidal Boulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nidal Boulos more than expected).

Fields of papers citing papers by Nidal Boulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nidal Boulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nidal Boulos. The network helps show where Nidal Boulos may publish in the future.

Co-authorship network of co-authors of Nidal Boulos

This figure shows the co-authorship network connecting the top 25 collaborators of Nidal Boulos. A scholar is included among the top collaborators of Nidal Boulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nidal Boulos. Nidal Boulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Muenzer, Joseph, Carole Ho, Heather Lau, et al.. (2024). Community consensus for Heparan sulfate as a biomarker to support accelerated approval in Neuronopathic Mucopolysaccharidoses. Molecular Genetics and Metabolism. 142(4). 108535–108535. 5 indexed citations

2.

Veerapandiyan, Aravindhan, Vamshi K. Rao, Carolina Tesi Rocha, et al.. (2024). 407P RGX-202, an investigational gene therapy for the treatment of Duchenne muscular dystrophy: interim clinical data. Neuromuscular Disorders. 43. 104441.278–104441.278.

3.

Harmatz, Paul, Can Fıçıcıoğlu, Roberto Giugliani, et al.. (2024). CAMPSIITE™ phase I/II/III: An interim clinical study update of RGX-121, an investigational gene therapy for the treatment of neuronopathic mucopolysaccharidosis type II (MPS II). Molecular Genetics and Metabolism. 141(2). 107874–107874. 1 indexed citations

4.

Nimmervoll, Birgit, Nidal Boulos, Jason Dapper, et al.. (2018). Establishing a Preclinical Multidisciplinary Board for Brain Tumors. Clinical Cancer Research. 24(7). 1654–1666. 9 indexed citations

5.

Jacus, Megan O., April Davis, Nidal Boulos, et al.. (2016). Simvastatin Hydroxy Acid Fails to Attain Sufficient Central Nervous System Tumor Exposure to Achieve a Cytotoxic Effect: Results of a Preclinical Cerebral Microdialysis Study. Drug Metabolism and Disposition. 44(4). 591–594. 3 indexed citations

6.

Phoenix, Timothy N., Deanna M. Patmore, Nidal Boulos, et al.. (2016). Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype. Cancer Cell. 29(4). 508–522. 231 indexed citations

7.

Wright, Karen, Vinay M. Daryani, David C. Turner, et al.. (2015). Phase I study of 5-fluorouracil in children and young adults with recurrent ependymoma. Neuro-Oncology. 17(12). 1620–1627. 23 indexed citations

8.

Patel, Yogesh T., Megan O. Jacus, Nidal Boulos, et al.. (2015). Preclinical examination of clofarabine in pediatric ependymoma: intratumoral concentrations insufficient to warrant further study. Cancer Chemotherapy and Pharmacology. 75(5). 897–906. 6 indexed citations

9.

Mohankumar, Kumarasamypet M., D. Spencer Currle, Elsie White, et al.. (2015). An in vivo screen identifies ependymoma oncogenes and tumor-suppressor genes. Nature Genetics. 47(8). 878–887. 47 indexed citations

10.

Morfouace, Marie, Birgit Nimmervoll, Nidal Boulos, et al.. (2015). Preclinical studies of 5-fluoro-2′-deoxycytidine and tetrahydrouridine in pediatric brain tumors. Journal of Neuro-Oncology. 126(2). 225–234. 11 indexed citations

11.

Murugesan, M., Timothy N. Phoenix, Birgit Nimmervoll, et al.. (2014). Orthotopic models of pediatric brain tumors in zebrafish. Oncogene. 34(13). 1736–1742. 42 indexed citations

12.

Singh, Harpreet, Anang A. Shelat, Amandeep Singh, et al.. (2013). A Screening-Based Approach to Circumvent Tumor Microenvironment-Driven Intrinsic Resistance to BCR-ABL+ Inhibitors in Ph+ Acute Lymphoblastic Leukemia. SLAS DISCOVERY. 19(1). 158–167. 10 indexed citations

13.

Jacus, Megan O., Stacy L. Throm, David C. Turner, et al.. (2013). Deriving therapies for children with primary CNS tumors using pharmacokinetic modeling and simulation of cerebral microdialysis data. European Journal of Pharmaceutical Sciences. 57. 41–47. 16 indexed citations

14.

Boulos, Nidal, et al.. (2012). Identification and characterisation of STMN4 and ROBO2 gene involvement in neuroblastoma cell differentiation. Cancer Letters. 328(1). 168–175. 15 indexed citations

15.

Boulos, Nidal, Heather L. Mulder, Christopher Calabrese, et al.. (2011). Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome–positive acute lymphoblastic leukemia. Blood. 117(13). 3585–3595. 54 indexed citations

16.

Zhang, Fan, Michael Tagen, Stacy L. Throm, et al.. (2010). Whole-Body Physiologically Based Pharmacokinetic Model for Nutlin-3a in Mice after Intravenous and Oral Administration. Drug Metabolism and Disposition. 39(1). 15–21. 46 indexed citations

17.

Caddy, Jacinta, Tomasz Wilanowski, Charbel Darido, et al.. (2010). Epidermal Wound Repair Is Regulated by the Planar Cell Polarity Signaling Pathway. Developmental Cell. 19(2). 353–353. 2 indexed citations

18.

Caddy, Jacinta, Tomasz Wilanowski, Charbel Darido, et al.. (2010). Epidermal Wound Repair Is Regulated by the Planar Cell Polarity Signaling Pathway. Developmental Cell. 19(1). 138–147. 157 indexed citations

19.

Collins-Underwood, J. Racquel, Nidal Boulos, Debbie Payne-Turner, et al.. (2010). The Role of Dominant-Negative IKAROS Mutations In the Pathogenesis and Treatment Responsiveness of BCR-ABL1 positive Acute Lymphoblastic Leukemia. Blood. 116(21). 540–540. 2 indexed citations

20.

Williams, Richard T., Willem den Besten, Nidal Boulos, & Charles J. Sherr. (2007). Cytokine-Dependent Imatinib Resistance in Mouse Bcr-Abl(+), Arf-Null Lymphoblastic Leukemia.. Blood. 110(11). 2632–2632. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact